首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷核子醫學

市場調查報告書

商品編碼

1729417

日本放射性藥物市場報告（按產品類型、應用、最終用途和地區）2025-2033

Japan Radiopharmaceuticals Market Report by Product Type, Application, End Use, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 122 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024 年，日本放射性藥物市場規模達 2.558 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 6.292 億美元，2025-2033 年期間的成長率 (CAGR) 為 9.73%。癌症、心血管疾病和神經系統疾病等慢性疾病的發生率不斷上升，導致對診斷和治療放射性藥物的需求增加，從而推動了市場的發展。

放射性藥物是含有放射性成分（通常是少量放射性同位素）與生物活性分子結合的專用藥物。它們在核子醫學中用於診斷和治療目的。在診斷應用中，將放射性藥物施用於患者，並使用伽馬相機或 PET 掃描儀等影像設備檢測其放射性輻射。這使得醫療保健專業人員能夠觀察和評估體內的各種生理過程，例如血流、器官功能或癌症等特定疾病的存在。放射性藥物也可用於治療某些疾病，如甲狀腺疾病和某些類型的癌症。在這些情況下，放射性成分針對特定細胞或組織，提供局部劑量的輻射，從而破壞或控制異常細胞的生長。總體而言，放射性藥物在現代醫學中發揮著至關重要的作用，它為診斷提供有價值的資訊，為特定疾病提供有效的治療方案，同時最大限度地減少對周圍健康組織的輻射暴露。

日本放射性藥物市場趨勢：

由於幾個關鍵促進因素，日本放射性藥物市場正在經歷強勁成長。首先，癌症和心血管疾病等慢性疾病的發生率不斷上升，推動了對診斷和治療放射性藥物的需求。此外，日本老齡化人口的不斷成長也增加了對先進診斷工具的需求，進一步推動了市場擴張。此外，放射性藥物生產和成像技術的進步使得這些藥物更加安全、有效，並提高了醫療保健提供者對其的採用率。此外，醫療保健專業人員和患者對早期疾病檢測和標靶治療益處的認知不斷提高，這也促進了市場的成長。製藥公司和研究機構合作推出新型放射性藥物也推動了市場擴張。此外，放射性藥物在個人化醫療中的應用不斷擴大，以及其在精準治療策略中的潛力，為市場發展開闢了新的途徑，預計將在未來幾年推動日本市場的發展。

日本放射性藥物市場細分：

產品類型洞察：

診斷核子醫學
治療核子醫學

應用程式洞察：

腫瘤學
心臟病學
神經病學
內分泌學
其他

最終用途洞察：

醫院和診所
研究機構
診斷中心

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外，也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本放射性藥物市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本放射性藥物市場有何影響？
根據產品類型，日本放射性藥物市場是如何分類的？
日本放射性藥物市場根據應用如何分類？
根據最終用途，日本放射性藥物市場是如何分類的？
日本放射性藥物市場的價值鏈分為哪些階段？
日本放射性藥物的主要促進因素和挑戰是什麼？
日本放射性藥物市場的結構是怎麼樣的？主要參與者是誰？
日本放射性藥物市場的競爭程度如何？

本報告回答的關鍵問題：

日本放射性藥物市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本放射性藥物市場有何影響？
根據產品類型，日本放射性藥物市場是如何分類的？
日本放射性藥物市場根據應用如何分類？
根據最終用途，日本放射性藥物市場是如何分類的？
日本放射性藥物市場的價值鏈分為哪些階段？
日本放射性藥物的主要促進因素和挑戰是什麼？
日本放射性藥物市場的結構是怎麼樣的？主要參與者是誰？
日本放射性藥物市場的競爭程度如何？

Japan radiopharmaceuticals market size reached USD 255.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 629.2 Million by 2033, exhibiting a growth rate (CAGR) of 9.73% during 2025-2033. The rising prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions that has led to an increased demand for diagnostic and therapeutic radiopharmaceuticals, is driving the market.

Radiopharmaceuticals are specialized drugs that contain a radioactive component, typically a small amount of a radioactive isotope, combined with a biologically active molecule. They are used in nuclear medicine for diagnostic and therapeutic purposes. In diagnostic applications, radiopharmaceuticals are administered to patients, and their radioactive emissions are detected using imaging equipment like gamma cameras or PET scanners. This allows healthcare professionals to visualize and assess various physiological processes within the body, such as blood flow, organ function, or the presence of specific diseases like cancer. Radiopharmaceuticals can also be used in therapeutic applications to treat certain medical conditions, such as thyroid disorders and some types of cancer. In these cases, the radioactive component is targeted to specific cells or tissues to deliver a localized dose of radiation, which can destroy or control the growth of abnormal cells. Overall, radiopharmaceuticals play a crucial role in modern medicine by providing valuable information for diagnosis and offering effective treatment options for specific diseases, all while minimizing radiation exposure to surrounding healthy tissues.

Japan Radiopharmaceuticals Market Trends:

The radiopharmaceuticals market in Japan is experiencing robust growth due to several key drivers. Firstly, the increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, has propelled the demand for diagnostic and therapeutic radiopharmaceuticals. Additionally, the growing aging population in Japan has augmented the need for advanced diagnostic tools, further fueling market expansion. Moreover, technological advancements in radiopharmaceutical production and imaging techniques have made these agents safer and more effective, boosting their adoption rates among healthcare providers. Furthermore, a rising awareness among both healthcare professionals and patients about the benefits of early disease detection and targeted therapy has contributed to the market's growth. Collaborative efforts between pharmaceutical companies and research institutions to launch novel radiopharmaceuticals have also propelled market expansion. Furthermore, the expanding application of radiopharmaceuticals in personalized medicine and their potential for precision treatment strategies, which have opened up new avenues for market development, is expected to drive the market in Japan in the coming years.

Japan Radiopharmaceuticals Market Segmentation:

Product Type Insights:

Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine

Application Insights:

Oncology
Cardiology
Neurology
Endocrinology
Others

End Use Insights:

Hospitals and Clinics
Research Institutes
Diagnostic Centers

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan radiopharmaceuticals market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan radiopharmaceuticals market?
What is the breakup of the Japan radiopharmaceuticals market on the basis of product type?
What is the breakup of the Japan radiopharmaceuticals market on the basis of application?
What is the breakup of the Japan radiopharmaceuticals market on the basis of end use?
What are the various stages in the value chain of the Japan radiopharmaceuticals market?
What are the key driving factors and challenges in the Japan radiopharmaceuticals?
What is the structure of the Japan radiopharmaceuticals market and who are the key players?
What is the degree of competition in the Japan radiopharmaceuticals market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Radiopharmaceuticals Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Radiopharmaceuticals Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Radiopharmaceuticals Market - Breakup by Product Type

6.1 Diagnostic Nuclear Medicine
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Therapeutic Nuclear Medicine
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)

7 Japan Radiopharmaceuticals Market - Breakup by Application

7.1 Oncology
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Cardiology
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
7.3 Neurology
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
7.4 Endocrinology
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
7.5 Others
- 7.5.1 Historical and Current Market Trends (2019-2024)
- 7.5.2 Market Forecast (2025-2033)

8 Japan Radiopharmaceuticals Market - Breakup by End Use

8.1 Hospitals and Clinics
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Research Institutes
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Diagnostic Centers
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Radiopharmaceuticals Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 Company A
- 10.1.1 Business Overview
- 10.1.2 Product Portfolio
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 Company B
- 10.2.1 Business Overview
- 10.2.2 Product Portfolio
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Company C
- 10.3.1 Business Overview
- 10.3.2 Product Portfolio
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Company D
- 10.4.1 Business Overview
- 10.4.2 Product Portfolio
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Company E
- 10.5.1 Business Overview
- 10.5.2 Product Portfolio
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events

11 Japan Radiopharmaceuticals Market - Industry Analysis

11.1 Drivers, Restraints and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis